PMAQX
Price
$47.98
Change
+$0.48 (+1.01%)
Updated
Sep 4 closing price
Net Assets
33.05B
SMFYX
Price
$42.60
Change
+$0.32 (+0.76%)
Updated
Sep 4 closing price
Net Assets
683.11M
Interact to see
Advertisement

PMAQX vs SMFYX

Header iconPMAQX vs SMFYX Comparison
Open Charts PMAQX vs SMFYXBanner chart's image
Principal MidCap R6
Price$47.98
Change+$0.48 (+1.01%)
VolumeN/A
Net Assets33.05B
American Beacon Stephens Mid-Cap Gr Y
Price$42.60
Change+$0.32 (+0.76%)
VolumeN/A
Net Assets683.11M
PMAQX vs SMFYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. SMFYX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a StrongBuy and SMFYX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. SMFYX (683M). PMAQX pays higher dividends than SMFYX: PMAQX (0.18) vs SMFYX (0.00). PMAQX was incepted earlier than SMFYX: PMAQX (9 years) vs SMFYX (14 years). SMFYX (0.99) is less costly to investors than PMAQX (0.59). SMFYX is a more actively managed with annual turnover of: 24.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than SMFYX: PMAQX (0) vs SMFYX (100000). SMFYX annual gain was more profitable for investors over the last year : 17.81 vs. PMAQX (9.84). PMAQX return over 5 years is better than : 50.22 vs. SMFYX (36.10).
PMAQXSMFYXPMAQX / SMFYX
Total Expense Ratio0.590.9661%
Annual Report Gross Expense Ratio0.590.9960%
Fund Existence9 years14 years-
Gain YTD7.50612.55060%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets33B683M4,832%
Annual Yield % from dividends0.180.00-
Returns for 1 year9.8417.8155%
Returns for 3 years47.8749.2697%
Returns for 5 years50.2236.10139%
Returns for 10 yearsN/A120.46-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INKT14.801.05
+7.64%
MiNK Therapeutics Inc
TSSI13.710.77
+5.95%
TSS.Inc
HI26.230.46
+1.79%
Hillenbrand
MDGL432.891.68
+0.39%
Madrigal Pharmaceuticals
DRDBU10.50N/A
N/A
Roman DBDR Acquisition Corp. II